Illinois Administrative Code

Section 1400.30 Payment of Application Fee (Repealed) (Source: Repealed at 18 Ill. Reg. 10712, effective June 30, 1994)

Section 1400.40 Financial Feasibility Costs (Repealed) (Source: Repealed at 20 Ill. Reg. 5831, effective April 12, 1996)

Section 1400.5 Fees and Costs Applicable to the Sale of Bonds (Repealed) (Source: Repealed at 20 Ill. Reg. 5831, effective April 12, 1996)

Section 1400.50 Bond Rating Agency Fees (Repealed) (Source: Repealed at 20 Ill. Reg. 5831, effective April 12, 1996)

Section 1400.60 Printing Costs (Repealed) (Source: Repealed at 20 Ill. Reg. 5831, effective April 12, 1996)

Section 1400.70 Bond Counsel (Repealed) (Source: Repealed at 20 Ill. Reg. 5831, effective April 12, 1996)

Section 1400.80 Trustee Fees (Repealed) (Source: Repealed at 20 Ill. Reg. 5831, effective April 12, 1996)

Section 1400.90 Title Insurance (Repealed) (Source: Repealed at 20 Ill. Reg. 5831, effective April 12, 1996)

Section 1400.TABLE A Authority Application (Except for short-term financing etc.) (Repealed) (Source: Repealed at 18 Ill. Reg. 10712, effective June 30, 1994)

Section 2075.10 Confidentiality of research subjects a) Any person authorized to conduct research in controlled substances under the Illinois Controlled Substances Act [720 ILCS 570], who intends to maintain the confidentiality of those persons who are the subjects of such resear…

Section 2080.10 Authority This Part is promulgated pursuant to the Illinois Controlled Substances Act (the Act) [720 ILCS 570] which empowers the Department of Human Services to codify the efforts of this State to conform with the regulatory systems of the federal government and …

Section 2080.100 Dispenser Responsibility a) Each time a Schedule II-V drug or other selected drugs, as described in Section 2080.230, is dispensed, the dispenser must transmit electronically, by the end of the business day, to the central repository the following data, and any o…

Section 2080.110 Partial filling of prescriptions (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.120 Emergency situations (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.130 Prescriptions from out-of-state prescribers and exempt Federal practitioners (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.140 Exemption for prescribers in hospitals and institutions (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.150 Exemptions for long term care and home infusion services (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.160 Exemptions for narcotic treatment programs (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.170 Exemptions for research (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.180 Investigatory and regulatory referrals (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.190 Reports a) For the purpose of intervention to prevent misuse, a prescriber or dispenser may request that reports about their patients be sent to them via a secure method if a patient meets the current PMP indications of potential misuse criteria set forth by the …

Section 2080.20 Incorporation by Reference and Definitions No incorporations by reference in this Part include any later amendments or editions. The definitions that apply to this Part are those found in the Act. "Act" means the Illinois Controlled Substances Act [720 ILCS 570]. …

Section 2080.200 Prescriber and Dispenser Inquiry System The Department's Bureau of Pharmacy and Clinical Support Systems or successor shall establish, operate, maintain, and enhance a stand-alone, one-to-one secure link with the necessary encrypted software that shall function a…

Section 2080.203 Registering with the ILPMP Each prescriber possessing an Illinois Controlled Substance License shall register with the ILPMP at the ILPMP website. (Source: Added at 47 Ill. Reg. 13500, effective September 8, 2023)

Section 2080.205 Accessing the ILPMP a) Prescribers or dispensers or their authorized designee may utilize the ILPMP for patient care after obtaining access authorization from the ILPMP staff. b) Each prescriber or their designee shall also document an attempt to access patient i…

Section 2080.207 EHR Integration with the ILPMP As required under 720 ILCS 570/318(j), based upon federal, initial and maintenance funding, a prescriber and dispenser inquiry system shall be developed to assist the health care community in its goal of effective clinical practice …

Section 2080.208 Pharmacy Management Systems Integration with the ILPMP As required under 720 ILCS 570/318(j), based upon federal, initial and maintenance funding, a prescriber and dispenser inquiry system shall be developed to assist the health care community in its goal of effe…

Section 2080.210 Access to the Prescription Information Library (PIL) (Repealed) (Source: Repealed at 47 Ill. Reg. 13500, effective September 8, 2023)

Section 2080.211 Other State Prescription Monitoring Authority Access a) Other states may request access to the PMP database: 1) After approval of a Memorandum of Understanding from the Illinois Department of Human Services; and 2) After approval from the Department's Bureau of P…

Section 2080.220 Error Reporting a) If a prescriber notices an error in their prescription information, they shall report it to the dispensing pharmacy within 7 days after discovery of the error. b) A dispenser who notices an error in a prescription they have dispensed and transm…

Section 2080.230 Designated Controlled Substances and Other Selected Drugs For tracking purposes, the Department, upon recommendation of the PMPAC, may designate and list drugs, other substances, and immediate precursors as: a) A Schedule I if the Department finds that: 1) the su…

Section 2080.240 Mid-Level Practitioners Prescriptive Authority Reporting In order to prevent erroneous association of prescriptions and remain compliant with the PMP, any supervising or collaborating physician who has delegated prescriptive authority to a mid-level practitioner …

Section 2080.245 Advanced Practice Registered Nurse with Full Practice Authority a) An advanced practice registered nurse granted Full Practice Authority under 225 ILCS 65/65-43 who prescribes Schedule II narcotic drugs, such as opioids, shall establish a consulting relationship …

Section 2080.250 Mailing of Controlled Substances a) Controlled substances may be mailed if all of the following conditions are met: 1) The controlled substances are not outwardly dangerous and are not likely, of their own force, to cause injury to a person's life or health. 2) T…

Section 2080.30 General Description The ILPMP monitors all prescriptions for Schedule II-V drugs and drugs of interest (i.e., select drugs that are not included in Schedule II, III, IV or V) that are dispensed (except for hospital inpatients unless required by 720 ILCS 570/313) w…

Section 2080.320 Illinois Prescription Monitoring Program Advisory Committee (ILPMPAC) The Illinois Prescription Monitoring Program Advisory Committee (ILPMPAC) is established to aid in the implementation of the ILPMP and to advise the Clinical Director on the professional perfor…

Section 2080.325 Peer Review Committee The ILPMPAC is authorized to have a standing subcommittee. This subcommittee shall be a ten-member Peer Review Committee. The Peer Review Committee shall advise the ILPMP on matters relating to the advisory committee's field of competence, e…

Section 2080.40 Official Triplicate Prescription Blanks (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.50 Authorized Prescribers A prescription for a Schedule II-V drug shall be issued only by a prescriber who: a) Possesses a valid professional license issued by DFPR as a physician licensed to practice medicine in all of its branches, dentist, optometrist, podiatrist,…

Section 2080.60 Application (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.70 Schedule II-V Drug Prescription Requirements a) A dispenser may fill a prescription for a Schedule II-V drug upon receipt of a written, electronic, facsimile, or verbal order of a prescriber unless otherwise specifically exempted or allowed by federal or State law…

Section 2080.80 Prohibited use of the Official Triplicate Prescription Blank (Repealed) (Source: Repealed at 26 Ill. Reg. 3975, effective March 4, 2002)

Section 2080.90 Dispensing a Schedule II, III, IV or V Drug A prescriber who administers a Schedule II, III, IV or V drug in the course of the prescriber's professional practice subject to the Act may do so without issuing a written prescription for that drug. (Source: Amended at…

Section 2081.10 Authority This Part is promulgated pursuant to the Illinois Controlled Substances Act that empowers the Department of Human Services to codify the efforts of this State to conform with the regulatory systems of the federal government and other states to establish …

Section 2081.20 Definitions and Incorporation by Reference No incorporations by reference in this Part include any later amendments or editions. The definitions that apply to this Part are those found in the Act and those in this Section. "Act" means the Illinois Controlled Subst…

Section 2081.30 General Description The PMP monitors all controlled substances for Schedule II, III, IV and V drugs that are dispensed within the State of Illinois, except for those dispensed to hospital inpatients and by drug abuse treatment programs licensed by the Department. …

Section 2081.40 Long Term Care Pharmacies Responsibility LTC pharmacies shall transmit the patient medication profiles to the PMP weekly (see 720 ILCS 570/316(c)). The Department shall impose a civil fine of $100 per day for willful failure to comply with statutory reporting requ…

Section 2081.50 Error Reporting a) If a prescriber notices an error in his or her prescription information, that prescriber shall report it to the Department by using the built-in PMP error reporting system within 7 days after discovery of the error. b) A dispenser who notices an…

Section 2081.60 Long Term Care Clinical Information (Repealed) (Source: Repealed at 47 Ill. Reg. 10948, effective July 7, 2023)

Section 2081.70 Designated Medications For tracking purposes, the Department, by recommendation of the PMPAC may designate and list drugs, other substances or immediate precursors as: a) A Schedule I, if the Department finds that: 1) the substance has high potential for abuse; an…